Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2020 Mar 30;396:114982. doi: 10.1016/j.taap.2020.114982

Fig. 3.

Fig. 3.

Alda-1 does not alter formation of NAPQI-protein adducts after APAP. Livers were harvested 2 h after vehicle only, APAP and APAP plus Alda-1 treatments. NAPQI-protein adducts were measured by HPLC. Values are mean ± SEM (n = 5/group). *, p < .01 vs. Vehicle.